Rokshaw can today announce the exclusive UK manufacture and distribution of medical cannabis products under the Four20 Pharma brand.
In line with market growth and patient demand, Rokshaw has bolstered its extensive range of medical cannabis, supplying Four20 Pharma products now available for private prescription in the UK.
Originating from Germany, Four20 Pharma have a EU-GMP approved portfolio of high quality strains and terpene profiles. With unique growing conditions and preparation through cultivation processes, specific product profiles are selected to sit within this range. Manufacture and distribution from Rokshaw ensures a consistency of supply for specialist doctors to prescribe to their patients.
The Four20 Pharma range is now available for all doctors listed on the specialist register, to prescribe for their patients.
Jonathan Hodgson, CEO of Rokshaw: “We are very excited to able to bring the Four20 Pharma range of products to the UK, in addition to the extensive range that we already provide. We believe in giving specialist doctors across the UK a full range of high quality products to prescribe from and we see the Four20 Pharma range sitting within that as a premium category of treatment”
Richard Hodgson, Managing Director of Rokshaw: “Healthcare professionals across the UK are always looking for more high quality medical cannabis treatment to provide their patients. The Four20 Pharma range will presents a portfolio of premium products unmatched in the current UK market. As the UK market is developing, we are proud to continue developing the quality of our range.”
If you are a pharmacist or healthcare professional looking for more information, please visit our new medical cannabis page or contact us at [email protected]. If you are an interested patient, please visit Curaleaf Pharmacy.
Rokshaw are the UK-leading experts in the manufacture and distribution of medical cannabis as part of Curaleaf International, the biggest cannabis company in the world. With their in-house state-of-the-art UK MHRA approved manufacturing facility, along with a comprehensive quality management system, Rokshaw are meeting the growing patient demand for a consistent range of medical cannabis manufactured to EU-GMP standards, with varying dosage forms and levels of THC & CBD content.
As well as providing their own range of medical cannabis products, Rokshaw is proud to work with a number of high-quality partners who share the same vision of widening access to patients in the UK. Their capability to import bulk raw material and deliver a best-in-class manufacturing and distribution model for major medical cannabis brands is what sets us apart from the rest.
Rokshaw’s partner range, combined with our portfolio of UK-manufactured products represents the widest range on the market, giving specialist doctors a variety of treatment options for their patients.
The post Four20 Medical Cannabis Products Launched in the UK via Rokshaw appeared first on Cannabis Health News.
Go to Source
Author: Sponsored features editor
